DBV Technologies (DBVT) Net Margin Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3,082.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,120.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -653.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,849.00 |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | -190,139.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -190,139.00 |
| Dec 31, 2025 | -244,632.00 |
| Sep 30, 2025 | 164,421.00 |
| Jun 30, 2025 | -599.00 |
| Mar 31, 2025 | -144,400.00 |
| Dec 31, 2024 | -437,787.00 |
| Sep 30, 2024 | -213,417.00 |
| Jun 30, 2024 | -179,280.00 |
| Mar 31, 2024 | -100,635.00 |
| Dec 31, 2023 | -313,532.00 |
| Sep 30, 2023 | 12,795.00 |
| Jun 30, 2023 | 44,723.00 |
| Mar 31, 2023 | -28,098.00 |
| Dec 31, 2022 | 347,558.00 |
| Sep 30, 2022 | 98,304.00 |
| Jun 30, 2022 | 55,328.00 |
| Mar 31, 2022 | 34,516.00 |
| Dec 31, 2021 | -372,414.00 |
| Sep 30, 2021 | -107,208.00 |
| Mar 31, 2021 | -13,453.00 |
| Sep 30, 2020 | 44,628.00 |
| Sep 30, 2019 | 26,753.00 |
| Dec 31, 2015 | -1,643.00 |
| Jun 30, 2015 | -188,737.00 |